Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial.
Claudia K FoxJustin M ClarkKyle D RudserJustin R RyderAmy C GrossBrandon M NathanMuna SunniDonald R DengelCharles J BillingtonMegan O BensignorAaron S KellyPublished in: Obesity (Silver Spring, Md.) (2022)
Although not achieving statistical significance, exenatide XR, compared with placebo, may partly mitigate the propensity toward BMI rebound in adolescents who achieved initial weight loss with dietary intervention.